NIAID Now spoke with Dr. Keith Kaye in a new blog post on antimicrobial resistance.

Monday, May 6, 2019 Q&A: Antibiotic Resistance and the OVERCOME Trial As bacteria gain resistance to common antibiotics, infections are becoming more difficult to treat. A new Q&A on the NIAID Now blog features Dr. Keith Kaye, principal investigator in the OVERCOME trial, which seeks to understand the best ways to extend the lifespans of antibiotics as useful treatment options. NIAID Now spoke with Dr. Kaye about his work in this field, and about his goals for future studies. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107